665 related articles for article (PubMed ID: 23731619)
1. Energy management - a critical role in cancer induction?
Garland J
Crit Rev Oncol Hematol; 2013 Oct; 88(1):198-217. PubMed ID: 23731619
[TBL] [Abstract][Full Text] [Related]
2. Unravelling the complexity of signalling networks in cancer: A review of the increasing role for computational modelling.
Garland J
Crit Rev Oncol Hematol; 2017 Sep; 117():73-113. PubMed ID: 28807238
[TBL] [Abstract][Full Text] [Related]
3. Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.
Gyurkó DM; Veres DV; Módos D; Lenti K; Korcsmáros T; Csermely P
Semin Cancer Biol; 2013 Aug; 23(4):262-9. PubMed ID: 23796463
[TBL] [Abstract][Full Text] [Related]
4. A thermodynamic interpretation of malignancy: do the genes come later?
Hauptmann S
Med Hypotheses; 2002 Feb; 58(2):144-7. PubMed ID: 11812192
[TBL] [Abstract][Full Text] [Related]
5. [Kinematic deterministic chaos of fluids and fractal geometry in the carotid system].
Martín-Araguz A; Ruiz-Aláez A; García de la Rocha ML; Fernández-Armayor V; Delgado-Reyes S; Moreno-Martínez JM
Rev Neurol; 1997 Dec; 25(148):2021-31. PubMed ID: 9528050
[TBL] [Abstract][Full Text] [Related]
6. Cancer-related networks: a help to understand, predict and change malignant transformation.
Csermely P; Korcsmáros T
Semin Cancer Biol; 2013 Aug; 23(4):209-12. PubMed ID: 23831276
[TBL] [Abstract][Full Text] [Related]
7. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
8. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
Gatenby RA; Gawlinski ET
Cancer Res; 2003 Jul; 63(14):3847-54. PubMed ID: 12873971
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation- and progression-linked discriminants of malignancy.
Vora S; Halper JP; Knowles DM
Cancer Res; 1985 Jul; 45(7):2993-3001. PubMed ID: 3159473
[TBL] [Abstract][Full Text] [Related]
10. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture.
Weinstein IB
Cancer Res; 1988 Aug; 48(15):4135-43. PubMed ID: 3292040
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
12. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
Felsher DW
Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
[TBL] [Abstract][Full Text] [Related]
13. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
14. Mutation-induced protein interaction kinetics changes affect apoptotic network dynamic properties and facilitate oncogenesis.
Zhao L; Sun T; Pei J; Ouyang Q
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4046-54. PubMed ID: 26170328
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria malfunctions as mediators of stem-cells' related carcinogenesis: a hypothesis that supports the highly conserved profile of carcinogenesis.
Hatzi VI; Terzoudi GI; Pantelias GE; Makropoulos V
Med Hypotheses; 2013 Jan; 80(1):70-4. PubMed ID: 23111201
[TBL] [Abstract][Full Text] [Related]
16. ROS, autophagy, mitochondria and cancer: Ras, the hidden master?
Bellot GL; Liu D; Pervaiz S
Mitochondrion; 2013 May; 13(3):155-62. PubMed ID: 22750269
[TBL] [Abstract][Full Text] [Related]
17. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
18. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
Chen J; Miller EM; Gallo KA
Oncogene; 2010 Aug; 29(31):4399-411. PubMed ID: 20514022
[TBL] [Abstract][Full Text] [Related]
19. Mutations and altered expression of the human cancer genes: what they tell us about causes.
Devereux TR; Risinger JI; Barrett JC
IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
[TBL] [Abstract][Full Text] [Related]
20. Changing mutational and adaptive landscapes and the genesis of cancer.
Liggett LA; DeGregori J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
